Company intelligence / Profile preview

BioInsights

Ownership: Private
Development stage: Commercial

Overview

BioInsights publishes high-quality scientific content—journals, news commentary, technology updates—focused on cell and gene therapy and related fields. It provides up-to-date information for industry professionals via respected journal titles such as Cell & Gene Therapy Insights. The team has deep expertise in biosciences communication and works closely with clients to deliver marketing solutions for biotech/pharma companies.

Modalities: Cell therapyGene therapyImmunotherapyVaccinology
Industry: Consulting

Partnerships

No major pharma/biotech partnerships reported; collaborates with academic experts/authors for journal content.

Beyond the preview

Go deeper on BioInsights.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioInsights.

Explore the full profile